+91 780-304-0404

HIV Diagnostics and Treatment Market

Global HIV Diagnostics and Treatment Market Size, Share & Trends Analysis Report by Test Type (Antibody Test, Viral Identification Assays, CD4 Testing, Viral Load Testing, and Early Infant Diagnostics), by Diagnostic Product (Kits and Reagents, and Instruments), by Treatment (Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS), Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTIS), Integrase Inhibitors, and Others), and by End-User (Diagnostic Laboratory, Hospitals, Home Care Settings, Blood Bank, and Others) and Forecast 2019-2025
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: | Category : Medical Devices | Delivery Format: /

The global HIV diagnosis and treatment market is estimated to grow at a CAGR of 7.6%, during the forecast period. Rising incidence and prevalence rate of HIV infection across the globe coupled with the technological development of diagnostic tests, such as rapid CD4, EID test and regulatory authority such as approval of POC (point of care testing) for detection of HIV), is driving the market growth. According to the Joint United Nations Program on HIV and AIDS (UNAID), more than 36.7 million people across the globe have HIV and around 1.8 million children had HIV infection in 2017. The FDA performed the clinical value of HIV diagnostic assay and blood screening and regulates the study to create product standard and incorporated enhanced diagnostic methods to enables the safety of drugs and biologics. The multidisciplinary research program plays a vital role in the establishment of test kits, vaccines, therapeutics agents for utilization in AIDS. Government support will support the growth of the HIV diagnostics and treatment market. 

The HIV diagnosis and treatment market is growing due to government initiatives, rising awareness about HIV and growing number of blood donation is the reason for the increase in a number of AIDs infection. It is a basic requirement for the treatment of HIV in underdeveloped nation need for technological equipment; however, the scarcity of funds and inaccuracy of the tests and with unskilled professionals are hampering the market growth of HIV diagnostics and treatment market. 

Segmental Outlook

The global HIV diagnosis and treatment market is segmented on the basis of test type, diagnostic product, treatment, and end-users. Based on the test type, the market is segmented into the antibody test, viral identification assays, CD4 testing, viral load testing, and early infant diagnostics. The antibody test is further segmented into HIV-1 screening test, HIV-2 & group O diagnostics tests, and HIV-1 antibody confirmatory test. Based on products, the segment is bifurcated into kits and reagents, and instruments. On the basis of treatment, the market is segmented into NNRTIS, NRTIS, integrase inhibitors, and others. The end-users of HIV diagnostics and treatment are diagnostic laboratory, hospitals, home care settings, blood bank, and others. Among the types of tests, the antibody tests contribute a significant share in the market, owing to the rising awareness among people regarding HIV is pertaining to regular blood tests. 

Global HIV Diagnostics and Treatment Market Share by End-User, 2018 (%)

Global HIV Diagnostics and Treatment Market Share by End-User

Regional Outlook  

Geographically, the global HIV diagnostics and treatment market is classified into North America, Europe, Asia-Pacific, and Rest of the World. North America holds a significant share in the global HIV diagnosis and treatment market due to well-developed healthcare infrastructure coupled with the high prevalence of HIV/AIDS in the region. Government initiatives for the establishment of effective diagnostics products and treatment is another factor that fuels the market growth in the region. Moreover, the region has affordability for the adoption of advanced medical infrastructure and facilities, which in turn, drives growth of the HIV diagnostics and treatment market.  

Global HIV Diagnostics and Treatment Market Growth, by Region 2019-2025

Global HIV Diagnostics and Treatment Market Growth, by Region

Asia-Pacific will grow at considerable growth rate in the global market during the forecast period

Asia-Pacific is expected to witness considerable growth in the global HIV diagnosis and treatment market during the forecast period. This growth is mainly attributed to the high unmet demand for HIV testing and screening in the region. Growing awareness regarding HIV diagnosis and treatment along with the government initiatives and campaigns in emerging economies, such as India and China, are other factors driving the growth of the market.

Market Players Outlook

The main players functioning in the global HIV diagnosis and treatment market include Bristol-Myers Squibb Co., Merck & Co., Inc., GlaxoSmithKline PLC, F. Hoffmann-La Roche Ltd., bioMérieux SA, Gilead Sciences, Inc., Siemens AG, Sysmex Corp., and ViiV Healthcare. The key players in the market are contributing significantly by providing different types of products and through increasing their geographical presence across the globe.

The Report Covers

  • Market value data analysis of 2018 and forecast to 2025.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global HIV diagnosis and treatment market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Geography

1.2.3. By Stakeholders

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. Bristol-Myers Squibb Co.

3.3.1.1. Overview

3.3.1.2. Financial Analysis

3.3.1.3. SWOT Analysis

3.3.1.4. Recent Developments

3.3.2. Merck & Co., Inc.

3.3.2.1. Overview

3.3.2.2. Financial Analysis

3.3.2.3. SWOT Analysis

3.3.2.4. Recent Developments

3.3.3. GlaxoSmithKline PLC

3.3.3.1. Overview

3.3.3.2. Financial Analysis

3.3.3.3. SWOT Analysis

3.3.3.4. Recent Developments

3.3.4. Gilead Sciences, Inc.

3.3.4.1. Overview

3.3.4.2. Financial Analysis

3.3.4.3. SWOT Analysis

3.3.4.4. Recent Developments

3.3.5. ViiV Healthcare 

3.3.5.1. Overview

3.3.5.2. Financial Analysis

3.3.5.3. SWOT Analysis

3.3.5.4. Recent Developments

4. Market Determinants 

4.1. Motivators

4.2. Restraints

4.3. Opportunities 

5. Market Segmentation

5.1. Global HIV Diagnostics and Treatment Market by Test Type

5.1.1. Antibody Tests

5.1.1.1. HIV-1 Screening Tests

5.1.1.2. HIV-1 Antibody Confirmatory Tests

5.1.1.3. HIV-2 & Group O Diagnostics Tests

5.1.2. Viral Identification Assays

5.1.3. CD4 Testing

5.1.4. Viral Load Testing

5.1.5. Early Infant Diagnostics

5.2. Global HIV Diagnostics and Treatment Market by Diagnostics Products

5.2.1. Kits and Reagents

5.2.2. Instruments

5.3. Global HIV Diagnostics and Treatment Market by Treatment

5.3.1. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS)

5.3.2. Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTIS)

5.3.3. Integrase Inhibitors

5.3.4. Others (Protease Inhibitors (PIS))

5.4. Global HIV Diagnostics and Treatment Market by End-User

5.4.1. Diagnostics Laboratory

5.4.2. Hospitals

5.4.3. Blood Banks

5.4.4. Home Care Settings 

5.4.5. Others (Academic and Research Institutes)

6. Regional Analysis

6.1. North America

6.1.1. United States

6.1.2. Canada

6.2. Europe

6.2.1. UK

6.2.2. Germany

6.2.3. Italy

6.2.4. Spain

6.2.5. France

6.2.6. Rest of Europe

6.3. Asia-Pacific

6.3.1. China

6.3.2. India

6.3.3. Japan

6.3.4. Rest of Asia-Pacific

6.4. Rest of the World

7. Company Profiles

7.1. Abbott Laboratories

7.2. AbbVie Inc.

7.3. Becton, Dickinson and Co.

7.4. Bio-Rad Laboratories, Inc.

7.5. bioMérieux SA

7.6. Boehringer Ingelheim International GmbH

7.7. Bristol-Myers Squibb Co.

7.8. Cipla Inc.

7.9. F. Hoffmann-La Roche Ltd. 

7.10. Gilead Sciences, Inc. 

7.11. GlaxoSmithKline PLC

7.12. Hologic, Inc.

7.13. Johnson & Johnson Services, Inc. 

7.14. Merck & Co., Inc.

7.15. Mylan N.V.

7.16. Pfizer Inc.

7.17. QIAGEN N.V.

7.18. Siemens AG

7.19. Sysmex Corp.

7.20. ViiV Healthcare 

LIST OF TABLES

1. GLOBAL HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2018-2025 ($ MILLION)

2. GLOBAL ANTIBODY TESTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

3. GLOBAL VIRAL IDENTIFICATION ASSAYS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

4. GLOBAL CD4 TESTING RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

5. GLOBAL VIRAL LOAD TESTING RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

6. GLOBAL EARLY INFACT DIAGNOSTICS RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

7. GLOBAL HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC PRODUCT, 2018-2025 ($ MILLION) 

8. GLOBAL KITS AND REAGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

9. GLOBAL INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

10. GLOBAL HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)

11. GLOBAL NNRTIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

12. GLOBAL NRTIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

13. GLOBAL INTEGRASE INHIBITORS RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

14. GLOBAL OTHER PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

15. GLOBAL HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

16. GLOBAL DIAGNOSTIC LABORATORY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

17. GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

18. GLOBAL BLOOD BANKS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

19. GLOBAL HOME CARE SETTINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

20. GLOBAL OTHER END-USERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

21. GLOBAL HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)

22. NORTH AMERICA HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

23. NORTH AMERICAN HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2018-2025 ($ MILLION)

24. NORTH AMERICAN HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC PRODUCT, 2018-2025 ($ MILLION)

25. NORTH AMERICAN HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)

26. NORTH AMERICAN HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

27. EUROPEAN HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

28. EUROPEAN HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2018-2025 ($ MILLION)

29. EUROPEAN HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC PRODUCT, 2018-2025 ($ MILLION)

30. EUROPEAN HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)

31. EUROPEAN HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

32. ASIA-PACIFIC HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

33. ASIA-PACIFIC HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2018-2025 ($ MILLION)

34. ASIA-PACIFIC HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSTICS PRODUCT, 2018-2025 ($ MILLION)

35. ASIA-PACIFIC HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)

36. ASIA-PACIFIC HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

37. REST OF THE WORLD HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2018-2025 ($ MILLION)

38. REST OF THE WORLD HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOTIC PRODUCT, 2018-2025 ($ MILLION)

39. REST OF THE WORLD HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)

40. REST OF THE WORLD HIV DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

LIST OF FIGURES 

1. GLOBAL HIV DIAGNOSTICS AND TREATMENT MARKET SHARE BY TEST TYPE, 2018 VS 2025 (%)

2. GLOBAL HIV DIAGNOSTICS AND TREATMENT MARKET SHARE BY DIAGNOSTIC PRODUCT, 2018 VS 2025 (%)

3. GLOBAL HIV DIAGNOSTICS AND TREATMENT MARKET SHARE BY TREATMENT, 2018 VS 2025 (%)

4. GLOBAL HIV DIAGNOSTICS AND TREATMENT MARKET SHARE BY END-USER, 2018 VS 2025 (%)

5. GLOBAL HIV DIAGNOSTICS AND TREATMENT MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)

6. US HIV DIAGNOSTICS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

7. CANADA HIV DIAGNOSTICS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

8. UK HIV DIAGNOSTICS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

9. FRANCE HIV DIAGNOSTICS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

10. GERMANY HIV DIAGNOSTICS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

11. ITALY HIV DIAGNOSTICS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

12. SPAIN HIV DIAGNOSTICS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

13. ROE HIV DIAGNOSTICS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

14. INDIA HIV DIAGNOSTICS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

15. CHINA HIV DIAGNOSTICS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

16. JAPAN HIV DIAGNOSTICS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

17. REST OF ASIA-PACIFIC HIV DIAGNOSTICS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

18. REST OF THE WORLD HIV DIAGNOSTICS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

Choose License Type
    On Discount

100%
Secured Payment

Why buy from us?
  • Covers more than 15 major industries, which are further segmented into 90+ sectors
  • 65% of our clients are loyal customers
  • 120+ countries are covered in analysis
  • currently servicing 1000+ customers globally
  • 100+ paid data sources mined to research
  • Our expert team will assist you with all research need and customization
  • Our expert research analyst will resolve your every query before and after purchasing the report
Related Reports